Protected:
There is no excerpt because this is a protected post.
Blog
Anti-VEGF Battles: Eylea Overtakes Lucentis in Japan
In fiscal 2015, top selling drug in ophthalmic space in Japan was Eylea (62.7% increase vs. 2014) and it jumped from second place to surpass the former leader Lucentis (19.1% decrease vs. 2014). Still, Lucentis is increasing sales generator for Novartis Japan 3-rd year in a row. Lucentis Sales in […]
iPS Cell Regenerative Medicine to Rely on Donor Cells in Order to Cut 77% of Costs
From this autumn Kyoto University’s iPS Research Institute will start to supply iPS (induced pluripotent stem) cells for regenerative medicine to ten research labs and pharmaceutical companies. The special feature of these cells is that they are derived from blood cell type that matches about 20% of Japanese population and […]
Plan: Generics to increase from 60% to 80% by 2017
The Government of Japan plans to develop a plan by this summer that outlines the country’s road to fiscal rehabilitation. On April 27, 2015 a meeting was held to discuss ways to reign in social welfare expenditures. The Ministry of finance said that the social welfare will needs to limit […]
Average Nursing Care Premium Breaks Through ¥5000
(April 27, 2015 Tokyo) As of April 2015 the average monthly payment premium for Japanese nursing care insurance increased to 5514 yen. It is paid by people aged 65 and over. The amount exceeds 5000 yen for the first time since the Nursing Care Insurance was introduced in year 2000. Municipal […]
Top 15 of Best Selling Substances for Pharmaceutical Use in Japan in 2014
(April 24, 2015 Tokyo) Ever wondered what are the top performing pharmaceutical substances in Japan? Here are the top 15 best selling products for 2014. By sales amount (% change year on year) Amlodipine (-0.6) Sodium (-0.9) Calcium (-1.3) Magnesium (-0.3) Potassium (-2.1) Clopidogrel (13.3) Candesartan cilexetil (-13) Pyridoxine […]
Coverage Decisions: Pricing For Zimmer’s Trabecular Metal Augments and Monoblocks
(April 8, 2015 Tokyo) Today Japan’s Central Social Insurance Medical Council (Chuikyo) announced its pricing and reimbursement decision for medical devices named Trabecular Metal Augments and Monoblocks, manufactured by Zimmer Inc., Japan. Same price was determined for following devices: Tibial and Femoral Cone Augments, Tibial and Femoral Monoblocks. Decision classification: […]
PMDL Replaces PAL
PMDL Replaces PAL (November 25, 2014 Tokyo) New Pharmaceutical and Medical Device Law (PMDL) replaces the Pharmaceutical Affairs Law (PAL). Changes affect crucial areas such as QMS compliance, manufacturers’ approval system. There is separate chapter for medical devices, new requirements for package inserts and new third-party certification options, among other […]
New Requirements for Psychiatric Hospitals
This video is in Japanese. If you need a translated transcript, please let us know using Contact Us form. This video is in Japanese. If you need a translated transcript, please let us know using Contact Us form.
Chuikyo Reduces Review Time for Advanced Medical Care
Tokyo (March 12, 2014) — Japanese Central Social Insurance Medical Council (Chuikyo) approved a plan to use a combination of NHI covered medical care along with uninsured Advanced Medical Care (AMC) in healthcare facilities designated by the government as National Strategic Special Zone (NSSZ) in a bid to shorten down […]